IQoro is a patented, neuromuscular treatment method developed by MYoroface AB. The company was founded in 2012 in Hudiksvall. IQoro addresses the underlying cause of conditions such as reflux, heartburn, snoring, and swallowing difficulties. This treatment method is based on over 20 years of scientific research, with proven efficacy demonstrated in 17 reviewed and internationally published studies. These studies were funded by Swedish taxpayers and research grants. IQoro is a Class 1 medical device, CE-marked, and endorsed by the National Institute for Health and Care Excellence (NICE). Since May 2021, it has been procured by the National Health Service in the UK. For further information, please visit

Contact us at: [email protected]

Privacy Policy